Orthopedic Biomaterial Market, By Material Type (Glass-ceramic & Bioactive Glasses, Calcium Phosphate Cements, Polymer, Metals, Composites), By Application (Joint Replacement, Spine Implants, Orthobiologics, Viscosupplementation, Bio-resorbable Tissue Fix

Orthopedic Biomaterial Market, By Material Type (Glass-ceramic & Bioactive Glasses, Calcium Phosphate Cements, Polymer, Metals, Composites), By Application (Joint Replacement, Spine Implants, Orthobiologics, Viscosupplementation, Bio-resorbable Tissue Fixation, Others), By End User (Hospitals, Orthopedic Clinics, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Biomaterials are broadly used in medical procedures, such as orthopedics. Orthopedic biomaterials are derived from organic or synthetic materials that help in the restoration of the structural integrity of bones that are damaged due to trauma or disease. Orthopedic biomaterials are incorporated into the human body as part of devices designed to perform certain biological functions by substituting or repairing various tissues, such as ligaments, cartilage, bones, tendons, and others. The application sectors of the product include joint replacement, spine implants, orthobiologics, viscosupplementation, and bio-resorbable tissue fixation. Some key characteristics and types of orthopedic biomaterials include biocompatibility, wear resistance, corrosion resistance, and others. One of the key characteristics of orthopedic biomaterials is their biocompatibility. This means that these materials are designed to work in harmony with the human body without causing any adverse reactions. This is particularly important as these materials are often incorporated into the body as part of medical devices.Another important characteristic of orthopedic biomaterials is their wear resistance. Given that these materials are often used in joint replacements and other procedures that involve constant movement, it's crucial that they can withstand the wear and tear of daily activities. This ensures the longevity of the medical devices in which they are used.Corrosion resistance is another key feature of orthopedic biomaterials. This ensures that the biomaterials do not degrade or break down over time, which could potentially lead to complications.

Market Dynamics

The orthopedic biomaterial market is expected to witness significant growth owing to increasing aging population, technological advancements, increasing product launches or approvals by market players, and others. For instance, in March 2023, Invibio Biomaterial Solutions, a division of Victrex plc and a pioneer in the development of PEEK biomaterial solutions, announced the launch of PEEK-OPTIMA AM Filament, an implantable PEEK polymer optimized for additive manufacturing. PEEK (Polyetheretherketone) is a high-performance thermoplastic polymer with qualities that make it appropriate for orthopedic and spinal implant applications.

The new PEEK-OPTIMA AM filament increases Invibio's line of biocompatible polymers, which are currently available in powders, granules, and rods for injection molding and other processing processes. PEEK-OPTIMA is often utilized in orthopedic and spinal implant applications such as in spinal fusion surgery, as well as different components used in joint replacement treatments.

Key features of the study:

• This report provides an in-depth analysis of the global orthopedic biomaterial market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global orthopedic biomaterial market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include B. Braun Melsungen AG, CONMED Corp., Evonik Industries AG, Medtronic Plc., Smith & Nephew Plc., Stryker Corp., Victrex Plc. (Invibio Ltd.), and Zimmer Biomet Holdings Inc., Globus Medical, Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Koninklijke DSM N.V., and DePuy Synthes
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global orthopedic biomaterial market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orthopedic biomaterial market

Detailed Segmentation:

• By Material Type:
• Glass-ceramic & Bioactive Glasses
• Calcium Phosphate Cements
• Polymer
• Metals
• Composites
• By Application:
• Joint Replacement
• Spine Implants
• Orthobiologics
• Viscosupplementation
• Bio-resorbable Tissue Fixation
• Others
• By End User:
• Hospitals
• Orthopedic Clinics
• Others
• By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Company Profiles
• Braun Melsungen AG
• CONMED Corporation
• Evonik Industries AG
• Medtronic Plc.
• Smith & Nephew Plc.
• Stryker Corp
• Victrex Plc. (Invibio Ltd.)
• Zimmer Biomet Holdings
• Globus Medical
• Heraeus Holding GmbH
• Exactech Inc.
• Collagen Matrix Inc.
• Koninklijke DSM N.V.
• DePuy Synthes.